{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:09:28Z","timestamp":1773896968059,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T00:00:00Z","timestamp":1290988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/nrclinonc.2010.186","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T13:31:12Z","timestamp":1291037472000},"page":"677-678","source":"Crossref","is-referenced-by-count":2,"title":["Maintenance rituximab for relapsed follicular lymphoma"],"prefix":"10.1038","volume":"7","author":[{"given":"David","family":"Wrench","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Montoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,29]]},"reference":[{"key":"BFnrclinonc2010186_CR1","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1200\/JCO.2009.26.5827","volume":"28","author":"MH van Oers","year":"2010","unstructured":"van Oers, M. H.  et al. Rituximab maintenance treatment of relapsed\/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study. J. Clin. Oncol. 28, 2853\u20132858 (2010).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2010186_CR2","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1200\/JCO.2007.13.5376","volume":"26","author":"R Marcus","year":"2008","unstructured":"Marcus, R.  et al. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. J. Clin. Oncol. 26, 4579\u20134586 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2010186_CR3","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1182\/blood-2008-04-153189","volume":"112","author":"G Salles","year":"2008","unstructured":"Salles, G.  et al. Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study. Blood 112, 4824\u20134831 (2008).","journal-title":"Blood"},{"issue":"Suppl. 15","key":"BFnrclinonc2010186_CR4","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.1200\/jco.2010.28.15_suppl.8004","volume":"28","author":"G Salles","year":"2010","unstructured":"Salles, G.  et al. Rituximab maintenance for 2 years in patients with untreated high tumour burden follicular lymphoma after response to immunochemotherapy [abstract]. J. Clin. Oncol. 28 (Suppl. 15), 8004 (2010).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2010186_CR5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1200\/JCO.2008.18.1495","volume":"27","author":"JW Friedberg","year":"2009","unstructured":"Friedberg, J. W.  et al. Follicular lymphoma in the United States: first report of the national LymphoCare study. J. Clin. Oncol. 27, 1202\u20131208 (2009).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2010186_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1200\/JCO.1995.13.1.140","volume":"13","author":"PW Johnson","year":"1995","unstructured":"Johnson, P. W.  et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J. Clin. Oncol. 13, 140\u2013147 (1995).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2010186_CR7","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1200\/JCO.2009.22.7819","volume":"28","author":"E Bachy","year":"2010","unstructured":"Bachy, E.  et al. Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival\u2014a study from the Groupe d'Etude des Lymphomes de l'Adulte. J. Clin. Oncol. 28, 822\u2013829 (2010).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2010186_CR8","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1200\/JCO.2006.09.8327","volume":"25","author":"AZ Rohatiner","year":"2007","unstructured":"Rohatiner, A. Z.  et al. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up. J. Clin. Oncol. 25, 2554\u20132559 (2007).","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 15","key":"BFnrclinonc2010186_CR9","doi-asserted-by":"publisher","first-page":"8005","DOI":"10.1200\/jco.2010.28.15_suppl.8005","volume":"28","author":"R Pettengell","year":"2010","unstructured":"Pettengell, R.  et al. Randomized study of rituximab in patients with relapsed or resistant follicular lymphoma prior to high-dose therapy as in vivo purging and to maintain remission following high-dose therapy [abstract]. J. Clin. Oncol. 28 (Suppl. 15), 8005 (2010).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc2010186_CR10","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1200\/JCO.2009.26.9100","volume":"28","author":"KJ Thomson","year":"2010","unstructured":"Thomson, K. J.  et al. T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma. J. Clin. Oncol. 28, 3695\u20133700 (2010).","journal-title":"J. Clin. Oncol."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2010.186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2010.186","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2010.186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:05:03Z","timestamp":1684469103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2010.186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,29]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFnrclinonc2010186"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2010.186","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,29]]}}}